These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7818998)

  • 1. What are the clinical uses of insulin-like growth factor-I in acute and chronic renal failure?
    Hammerman MR
    Pediatr Nephrol; 1994 Oct; 8(5):544. PubMed ID: 7818998
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiology and potential use of insulin-like growth factor 1 in acute and chronic renal failure.
    Kopple JD; Ding H; Qing DP
    Nephrol Dial Transplant; 1998; 13 Suppl 1():34-9. PubMed ID: 9507496
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of growth hormone and insulin-like growth factor I on renal growth and function.
    Hammerman MR; Miller SB
    J Pediatr; 1997 Jul; 131(1 Pt 2):S17-9. PubMed ID: 9255221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic use of growth factors in renal failure.
    Hammerman MR; Miller SB
    J Am Soc Nephrol; 1994 Jul; 5(1):1-11. PubMed ID: 7948775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure.
    Hirschberg R; Kopple J; Lipsett P; Benjamin E; Minei J; Albertson T; Munger M; Metzler M; Zaloga G; Murray M; Lowry S; Conger J; McKeown W; O'shea M; Baughman R; Wood K; Haupt M; Kaiser R; Simms H; Warnock D; Summer W; Hintz R; Myers B; Haenftling K; Capra W
    Kidney Int; 1999 Jun; 55(6):2423-32. PubMed ID: 10354291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from acute ischaemic renal failure is accelerated by des-(1-3)-insulin-like growth factor-1.
    Clark R; Mortensen D; Rabkin R
    Clin Sci (Lond); 1994 Jun; 86(6):709-14. PubMed ID: 8062506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of growth factors to increase glomerular filtration rate in chronic renal failure patients.
    Miller SB; Rabkin R
    Curr Opin Nephrol Hypertens; 1997 Jul; 6(4):401-4. PubMed ID: 9263692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal replacement therapy in acute renal failure.
    Schiffl H; Lang SM
    Lancet; 2006 Oct; 368(9546):1491; author reply 1492. PubMed ID: 17071275
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin-like growth factor I treatment for end-stage renal disease at the end of the millennium.
    Hammerman MR
    Curr Opin Nephrol Hypertens; 2000 Jan; 9(1):1-3. PubMed ID: 10654817
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure.
    Ding H; Kopple JD; Cohen A; Hirschberg R
    J Clin Invest; 1993 May; 91(5):2281-7. PubMed ID: 8486787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The physiology and pathophysiology of IGF-I in the kidney.
    Hirschberg R
    Adv Exp Med Biol; 1993; 343():345-66. PubMed ID: 8184743
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin-like growth factor system and the kidney: physiology, pathophysiology, and therapeutic implications.
    Hirschberg R; Adler S
    Am J Kidney Dis; 1998 Jun; 31(6):901-19. PubMed ID: 9631833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Timing and dose in renal replacement therapy].
    Nalesso F; Giuliani A; Basso F; Brendolan A; Ronco C
    Cir Cir; 2013; 81(3):177-80. PubMed ID: 23769244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathophysiology and choice of treatment in acute renal failure].
    Sugimura K
    Nihon Rinsho; 2004 May; 62 Suppl 5():403-6. PubMed ID: 15197953
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin-like growth factor 1 resistance in chronic renal failure.
    Fouque D
    Miner Electrolyte Metab; 1996; 22(1-3):133-7. PubMed ID: 8676805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose furosemide (Lasix) in renal insufficiency.
    Seedat YK
    S Afr Med J; 1972 Sep; 46(38):1371-4. PubMed ID: 4638226
    [No Abstract]   [Full Text] [Related]  

  • 17. Biologically active peptides in acute renal failure: recent clinical trials.
    Hirschberg R
    Nephrol Dial Transplant; 1997 Aug; 12(8):1563-6. PubMed ID: 9269629
    [No Abstract]   [Full Text] [Related]  

  • 18. [Kidney in shock and shock-kidney. Pathogenesis, diagnosis and therapy].
    Commichau R
    Anasthesiol Intensivmed Prax; 1974; 9(1):85-92. PubMed ID: 4470365
    [No Abstract]   [Full Text] [Related]  

  • 19. Recapitulation of phylogeny by ontogeny in nephrology.
    Hammerman MR
    Kidney Int; 2000 Feb; 57(2):742-55. PubMed ID: 10652054
    [No Abstract]   [Full Text] [Related]  

  • 20. Timing of dialysis initiation in acute kidney injury and acute-on-chronic renal failure.
    Macedo E; Mehta RL
    Semin Dial; 2013; 26(6):675-81. PubMed ID: 24016050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.